tiprankstipranks
Trending News
More News >

Shin Nippon Biomedical Laboratories Announces Year-End Dividend

Story Highlights
  • Shin Nippon Biomedical Laboratories focuses on CRO services and stable profit distribution.
  • The company declared a year-end dividend of ¥30.00 per share, totaling ¥50.00 annually.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Shin Nippon Biomedical Laboratories Announces Year-End Dividend

Don’t Miss TipRanks’ Half-Year Sale

Shin Nippon Biomedical Laboratories, Ltd. ( (JP:2395) ) just unveiled an announcement.

Shin Nippon Biomedical Laboratories, Ltd. announced a year-end dividend payment of ¥30.00 per share for the fiscal year ended March 31, 2025, resulting in an annual dividend of ¥50.00 per share. This decision reflects the company’s solid performance in its CRO business, despite increased expenses from the FDA approval of Satsuma’s STS101, and aligns with its policy of stable profit distribution.

The most recent analyst rating on (JP:2395) stock is a Hold with a Yen1460.00 price target. To see the full list of analyst forecasts on Shin Nippon Biomedical Laboratories, Ltd. stock, see the JP:2395 Stock Forecast page.

More about Shin Nippon Biomedical Laboratories, Ltd.

Shin Nippon Biomedical Laboratories, Ltd. operates in the biomedical industry, focusing on contract research organization (CRO) services. The company is committed to providing stable profit distributions to shareholders and aims for a payout ratio of 30-40% on a consolidated basis.

Average Trading Volume: 405,215

Technical Sentiment Signal: Sell

Current Market Cap: Yen55.75B

For a thorough assessment of 2395 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1